News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.
Understanding the Current Investment Landscape: What Biotech Startups Need to Know
Cell & Gene

Understanding the Current Investment Landscape: What Biotech Startups Need to Know

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable
Cell & Gene

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable
Cell & Gene

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development
Proteins, Antibodies & ADCs

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development

Caribou Announces Positive Data for Off-the-Shelf CAR T
Cell & Gene

Caribou Announces Positive Data for Off-the-Shelf CAR T

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration
Cell & Gene

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration

MIT Develop New Method of AAV Manufacture for Gene Therapy
Cell & Gene

MIT Develop New Method of AAV Manufacture for Gene Therapy

GSK Acquires Rights to ADC for Prostate Cancer for £268m
Proteins, Antibodies & ADCs

GSK Acquires Rights to ADC for Prostate Cancer for £268m

Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID
Cell & Gene

Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID

COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine
Vaccines

COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery
Proteins, Antibodies & ADCs

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers
Proteins, Antibodies & ADCs

Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers

Three CGT Draft Guidance Documents Released by the FDA
Cell & Gene

Three CGT Draft Guidance Documents Released by the FDA

Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective
Proteins, Antibodies & ADCs

Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective

Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons
Proteins, Antibodies & ADCs

Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons

mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate
Vaccines

mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate

Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration
Proteins, Antibodies & ADCs

Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration

Analysis of Neuropeptide Function Using New Tool
Peptides

Analysis of Neuropeptide Function Using New Tool

“Dawn of a new age”: RNA Silencing Therapy Slows Huntington’s Disease by 75% in Clinical Trial
Cell & Gene

“Dawn of a new age”: RNA Silencing Therapy Slows Huntington’s Disease by 75% in Clinical Trial

Topical Gene Therapy for Rare Skin Disease Gets Expanded Label
Cell & Gene

Topical Gene Therapy for Rare Skin Disease Gets Expanded Label

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.